Abstract
A high incidence of pancreatitis in COVID-19 has been reported. Although a high proportion of critically unwell patients with COVID-19 have raised serum amylase levels, this does not necessarily reflect acute pancreatitis or a clinically important pancreatic injury.
All Keywords
【초록키워드】 COVID-19, serum, incidence, Pancreatitis, Injury, acute pancreatitis, serum amylase, Pancreatic Injury, amylase, proportion, reported, clinically, raised, pancreatic, patients with COVID-19, 【제목키워드】 serum, patients with COVID-19,
【초록키워드】 COVID-19, serum, incidence, Pancreatitis, Injury, acute pancreatitis, serum amylase, Pancreatic Injury, amylase, proportion, reported, clinically, raised, pancreatic, patients with COVID-19, 【제목키워드】 serum, patients with COVID-19,
{{{ 추상적인 }}}
COVID-19에서 췌장염의 높은 발병률이 보고되었습니다. 심각한 상태의 COVID-19 환자의 높은 비율이 혈청 아밀라아제 수치를 높였지만 이것이 반드시 급성 췌장염이나 임상적으로 중요한 췌장 손상을 반영하는 것은 아닙니다.